osteoarthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients aged 18-80 years (including boundary values), except pregnant women; (2) Patients requiring hip replacement or knee replacement or single condylar replacement; (3) Patients voluntarily participate in clinical trials and are willing to sign informed consent.
Exclusion criteria
Exclusion criteria: (1) BMI > 40; (2) Patients with neuromuscular dysfunction (e.g., paralysis, myolysis, or abductor weakness) resulting in hip instability or gait abnormalities after surgery; (3) Patients with a history of infection or existing suspected/confirmed infection of the hip or knee or other parts of the body; (4) Patients with sepsis or osteomyelitis; (5) Patients with ankylosing spondylitis with bone rigidity or severe rigidity; (6) The patient is known to have a history of allergy to one or more implanted materials; (7) Patients with primary or metastatic tumors or related history; (8) Patients whose hip or knee joint has been fused for a long time without pain and deformity; (9) Patients expected to have poor compliance; (10) Pregnant or lactating women, or patients who have a family plan during the clinical study; (11) The patient had participated in other drug clinical trials within 3 months before enrollment, or had participated in other device clinical trials within 1 month before enrollment; (12) Other situations in which the investigator considers it inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gait analysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Harris ;Western Ontario and McMaster University Osteoarthritis Index (WOMAC) ;visual analogue scale(VAS); | — |
Countries
China
Contacts
The Fourth Medical Centre, Chinese PLA General Hospital